0001415889-24-009205.txt : 20240327 0001415889-24-009205.hdr.sgml : 20240327 20240327162410 ACCESSION NUMBER: 0001415889-24-009205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240326 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RALLIS CHRIS A CENTRAL INDEX KEY: 0001185945 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32295 FILM NUMBER: 24791044 MAIL ADDRESS: STREET 1: C/O TENAX THERAPEUTICS, INC. STREET 2: ONE COPLEY PARKWAY, SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001211583 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (919) 636-4530 MAIL ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20140903 FORMER COMPANY: FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC DATE OF NAME CHANGE: 20021223 4 1 form4-03272024_080358.xml X0508 4 2024-03-26 0001211583 FENNEC PHARMACEUTICALS INC. FENC 0001185945 RALLIS CHRIS A C/O FENNEC PHARMACEUTICALS, INC. PO BOX 13628, 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 true false false false 1 Common Shares 2024-03-26 4 S 0 2114 10.97 D 40920 D Common Shares 2024-03-26 4 M 0 4329 2.31 A 45249 D Common Shares 2.31 2024-03-26 4 M 0 4329 2.31 D 2014-04-24 2024-04-25 Options 4239 182983 D Shares sold to satisfy tax obligation on option exercise. Shares acquired through the exercise of an option pusuant to a 10b5-1 plan adopted on August 17, 2023. Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023. /s/ Chris A. Rallis 2024-03-27